Hydroxychloroquine pre-exposure prophylaxis provides no protection against COVID-19 among health care workers: a cross-sectional study in a tertiary care hospital in North India
Author:
Affiliation:
1. Department of Clinical Pharmacology , Fortis Hospital Mohali , Mohali , India
2. Department of Pharmacology, University College of Medical Sciences , Delhi , India
3. Fortis Hospital Mohali , Mohali , Punjab , India
Abstract
Publisher
Walter de Gruyter GmbH
Subject
Drug Discovery,Pharmacology,General Medicine,Physiology
Link
https://www.degruyter.com/document/doi/10.1515/jbcpp-2021-0221/pdf
Reference14 articles.
1. COVID19 state wise status. Government of India. Available from: https://www.mygov.in/corona-data/covid19-statewise-status [Accessed 27 Jun 2020].
2. Recommendation for empiric use of hydroxy-chloroquine for prophylaxis of SARS-CoV-2. Indian Council for Medical Research 2020. Available from: https://icmr.nic.in/sites/default/files/upload_documents/HCQ_Recommendation_22March_final_MM_V2.pdf [Accessed 24 Apr 2020].
3. Gio, J, Tian, Z, Yang, X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 2020;14:72–3.
4. Revised advisory on the use of Hydroxychloroquine (HCQ) as prophylaxis for COVID-19 infection. Available from: https://www.mohfw.gov.in/pdf/RevisedadvisoryontheuseofhydroxychloroquineasprophylaxisforSARSCOVID19infection.pdf [Accessed 24 Apr 2020].
5. Ferner, RE, Aronson, JK. Chloroquine and hydroxychloroquine in COVID-19. BMJ 2020;369:1432. https://doi.org/10.1136/bmj.m1432.
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. COVID-19 patients’ clinical profile and outcome with respect to their vaccination status: A prospective observational multicentre cohort study during third wave in Western India;Indian Journal of Medical Microbiology;2023-01
2. Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein;Journal of Virology;2022-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3